demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 hospitalized
COVID-19 severe or critically
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo

1 studies excluded by filtering options 2

5570 CT-P59 1.2, 2020 210excludedrisk of bias not avaialble